Pravafenix is used in adults at high risk of heart disease whose low\-density\-lipoprotein (LDL) cholesterol is already being controlled with pravastatin alone or another medicine from the statin family, but who still need to improve their high\-density\-lipoprotein (HDL) cholesterol levels and reduce their levels of triglycerides (another type of fat) in the blood. Pravafenix is used in addition to other measures such as diet, exercise and weight reduction. Pravafenix contains the active substances pravastatin and fenofibrate.
Therapeutic Indication
Pravafenix is indicated as an adjunct to diet and other non\-pharmacological treatment (e.g. exercise, weight reduction) for the treatment of mixed hyperlipidaemia in adult patients at high cardiovascular risk to reduce triglycerides and increase HDL C when LDL C levels are adequately controlled while on a treatment with pravastatin 40 mg monotherapy or on another moderate\-intensity statin regimen.
Therapeutic Area (MeSH)
ATC Code
C10BA03
ATC Item
N/A
Pharmacotherapeutic Group
Lipid modifying agents
Active Substance (Summary)
INN / Common Names
EMA Name
Pravafenix
Medicine Name
Pravafenix
Aliases
N/ANo risk management plan link.
